The purpose of this study is to investigate the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having mild to moderate hyperlipidemia after 30 days of intervention.
In a randomized, double-blind, placebo control trial, the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) will be investigated in chronic smokers having mild to moderate hyperlipidemia. Sixty subjects will be randomly assigned to receive the dietary supplements and placebo for 30 days. The efficacy of the supplements will be measured by estimating cotinine and malondialdehyde level.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
60
Sreenivasa Clinic Diabetic Research Center
Bangalore, Karnataka, India
Change in urine cotinine and serum oxidative stress marker levels
nicotine metabolite (cotinine) and serum oxidative stress marker (malondialdehyde) levels
Time frame: Baseline and on day 30
Change in serum lipid profile
Low density lipoprotein-cholesterol (LDL-C), very low density lipoprotein-cholesterol (VLDL-C), high density lipoprotein-cholesterol (HDL-C), total cholesterol (TC)
Time frame: Baseline and on day 30
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.